KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) EBT Margin (2017 - 2026)

Moderna (MRNA) has disclosed EBT Margin for 10 consecutive years, with 342.93% as the latest value for Q1 2026.

  • For Q1 2026, EBT Margin rose 54966.0% year-over-year to 342.93%; the TTM value through Mar 2026 reached 141.03%, down 3159.0%, while the annual FY2025 figure was 142.39%, 3092.0% down from the prior year.
  • EBT Margin hit 342.93% in Q1 2026 for Moderna, down from 117.85% in the prior quarter.
  • Across five years, EBT Margin topped out at 69.72% in Q1 2022 and bottomed at 892.59% in Q1 2025.
  • Average EBT Margin over 5 years is 231.31%, with a median of 106.94% recorded in 2023.
  • Year-over-year, EBT Margin plummeted -68122bps in 2024 and then surged 54966bps in 2026.
  • Moderna's EBT Margin stood at 32.55% in 2022, then tumbled by -92bps to 2.49% in 2023, then crashed by -5022bps to 122.57% in 2024, then grew by 4bps to 117.85% in 2025, then plummeted by -191bps to 342.93% in 2026.
  • According to Business Quant data, EBT Margin over the past three periods came in at 342.93%, 117.85%, and 18.41% for Q1 2026, Q4 2025, and Q3 2025 respectively.